Scandion Oncology is a company developing drugs that specifically target chemotherapy resistance mechanisms. It aims to provide treatments that will re-sensitize cancer cells to chemotherapy within the metastatic colon and breast cancer. In addition, the company uses a screening platform that screens for the ability to restore drug sensitivity.
|Employees (est.) (Sept 2021)||19||(+6%)|
Scandion Oncology has 782 Twitter Followers. The number of followers has increased 1.5% month over month and increased 6.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Scandion Oncology founded?
Scandion Oncology was founded in 2017.
Who are Scandion Oncology key executives?
Scandion Oncology's key executives are Christian Vinding Thomsen, Peter Høngaard Andersen and Peter Michael Vestlev.
How many employees does Scandion Oncology have?
Scandion Oncology has 22 employees.
Who are Scandion Oncology competitors?
Competitors of Scandion Oncology include Rain Therapeutics, Medigen and Cascade Prodrug.
Where is Scandion Oncology headquarters?
Scandion Oncology headquarters is located at Fruebjergvej 3, København.
Where are Scandion Oncology offices?
Scandion Oncology has an office in København.
How many offices does Scandion Oncology have?
Scandion Oncology has 3 offices.
Receive alerts for 300+ data fields across thousands of companies